the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes. .
the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.� . .
-
.
http://lm360.us/Rocker-grandpa-of-Lupkin-from-Mississauga?Derobertis=146 taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.
-
..